JONES FINANCIAL COMPANIES LLLP
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 815917
DES PERES, MO
Position in PBH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,826,449
+$14,765,500 QoQ
Shares Held
250,151
+25218.9% QoQ
Ownership
0.528%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99.70497819317133.ToString("F0")%
Shared 0.ToString("F0")%
None 0.29502180682867546.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $151,859,373 across 48 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
9,086,528 | $90,956,145 | |
| 2 | ZTS |
Zoetis Inc.
|
179,646 | $21,235,953 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
250,151 | $14,826,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
321,219 | $9,675,116 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
2,135,741 | $5,851,930 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
23,151 | $3,049,911 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,960 | $1,755,220 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
54,322 | $675,222 |
All Filings in PBH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,826,449 | 250,151 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,949 | 988 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,500 | 617 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $56,612 | 709 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,348 | 132 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $5,544 | 71 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||